Commentary
Cancer patients should never have to question whether the medicine intended to help them is safe and authentic — particularly when health, and sometimes life, hangs in the balance.
From
To
Missouri
In the midst of navigating a turbulent divorce last year, Claire learned she was pregnant. “It wasn’t the right time for me to have a child,” said Claire, who lives in Kansas City and agreed to speak on the condition that she be identified by her first name, citing concerns for her privacy and the […]
Commentary
As a physician anesthesiologist, I see patients taking a GLP-1, like Ozempic, Wegovy, or Zepbound, every single day. Use of these drugs, originally intended for diabetes, has skyrocketed as people take them for weight loss, sleep apnea, and cardiovascular health. There is still much to learn about these medications, but we know they present challenges […]
Shreveport
SHREVEPORT, La. - A newly approved cholesterol-lowering medication could offer some patients another option to reduce their risk of heart disease.
States Newsroom
A brother of a woman detained by federal immigration agents in Louisville said she has been denied proper medical care for sickle cell anemia while being held in a Kentucky jail. Sarafina Bukirwa, 31, was on her way to a sickle cell anemia conference when her brother, Isaac Kabunga, dropped her off at the Louisville […]
Virginia
By Yiqing Wang/WHRO Howard Weinberg keeps his Parkinson’s medication in a small container attached to his keychain, so he always has it wherever he goes. The retired doctor from Virginia Beach has to take the medication every six hours, at 1 o’clock and 7 o’clock, day and night. For him, that schedule is not optional. […]
Illinois
(The Center Square) – U.S. Rep. Eric Sorensen, D-Illinois, is backing legislation he says would lower prescription drug costs by targeting the use of Food and Drug Administration citizen petitions that can delay generic drug competition. But critics argue the proposal could undermine an important regulatory process and discourage investment in new medicines.
(The Center Square) - The U.S. Supreme Court, in a unanimous decision on Thursday, ruled that a cardiovascular drugmaker did not violate America's patent laws. The ruling could allow for generic drug manufacturers to produce more without fear of patent lawsuits.
Shreveport
